MLTI-16. SYSTEMIC THERAPY FOLLOWING CRANIOTOMY IN PATIENTS WITH A SOLITARY BREAST CANCER BRAIN METASTASIS

INTRODUCTION: Between 15–50% of patients with metastatic breast cancer will develop brain metastases, with the frequency more common in patients with HER2-positive or triple-negative subtypes. Surgical resection is often indicated for diagnostic and/or therapeutic intent for patients presenting with...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Neurooncol Adv
Autors principals: Hulsbergen, Alexander, Cho, Logan, Mammi, Marco, Lamba, Nayan, Smith, Timothy, Broekman, Marike, Lin, Nancy
Format: Artigo
Idioma:Inglês
Publicat: Oxford University Press 2019
Matèries:
Abstracts
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7213430/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/noajnl/vdz014.075
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars